Literature DB >> 12098125

The effects of morphine on human articular cartilage of the knee: an in vitro study.

John W Jaureguito1, Joseph F Wilcox, Ronald A Thisted, Craig Phillips, Benjamin Cunningham, Bruce Reider.   

Abstract

PURPOSE: The purpose of this study was to determine the metabolic, histologic, and ultrastructural effects of morphine and its combination with saline and bupivacaine on human articular cartilage. TYPE OF STUDY: In vitro study.
METHODS: Nonfibrillated human articular cartilage was harvested and transferred into an experimental culture consisting of a control medium, saline, or a combination of morphine/saline or morphine/saline/bupivacaine for 12, 24, or 72 hours. Each sample was radiolabeled to assess proteoglycan synthesis. Histologic and ultrastructural effects were also examined.
RESULTS: We found a significant, dose-related, transient decrease in 35SO4 incorporation in the morphine/saline samples at 12 hours, and in the saline only samples at 24 hours. We found no evidence of histologic or ultrastructural damage to the cartilage.
CONCLUSIONS: Morphine and saline can both produce a transient decrease in 35SO4 incorporation that normalizes by 72 hours. This study does not suggest any contraindication to the use of intra-articular morphine as a postoperative analgesic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12098125     DOI: 10.1053/jars.2002.32587

Source DB:  PubMed          Journal:  Arthroscopy        ISSN: 0749-8063            Impact factor:   4.772


  9 in total

1.  Single-dose intra-articular bupivacaine plus morphine versus bupivacaine alone after arthroscopic knee surgery: a meta-analysis of randomized controlled trials.

Authors:  Ye Yang; Chao Zeng; Jie Wei; Hui Li; Tuo Yang; Zhen-Han Deng; Yu-Sheng Li; Tu-Bao Yang; Guang-Hua Lei
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-08-12       Impact factor: 4.342

Review 2.  Peripheral opioid analgesia: clinical applications.

Authors:  Jochen Oeltjenbruns; Michael Schäfer
Journal:  Curr Pain Headache Rep       Date:  2005-02

Review 3.  [Potential applications and significance of peripheral opioid analgesia].

Authors:  J Oeltjenbruns; M Schäfer
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

4.  Bupivacaine, ropivacaine, and morphine: comparison of toxicity on human hamstring-derived stem/progenitor cells.

Authors:  Florian Haasters; Hans Polzer; Wolf Christian Prall; Maximilian Michael Saller; Julia Kohler; Stefan Grote; Wolf Mutschler; Denitsa Docheva; Matthias Schieker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-06-07       Impact factor: 4.342

5.  The in vitro effects of bupivacaine on articular chondrocytes.

Authors:  C R Chu; N J Izzo; C H Coyle; N E Papas; A Logar
Journal:  J Bone Joint Surg Br       Date:  2008-06

6.  Single-dose intra-articular bupivacaine plus morphine after knee arthroscopic surgery: a meta-analysis of randomised placebo-controlled studies.

Authors:  Yi-lun Wang; Chao Zeng; Dong-xing Xie; Ye Yang; Jie Wei; Tuo Yang; Hui Li; Guang-hua Lei
Journal:  BMJ Open       Date:  2015-06-15       Impact factor: 2.692

7.  Effects of maternal consumption of morphine on rat skeletal system development.

Authors:  Maryam Saeidinezhad; Vahid Razban; Hosein Safizadeh; Massood Ezzatabadipour
Journal:  BMC Musculoskelet Disord       Date:  2021-05-13       Impact factor: 2.362

8.  Dexamethasone Does not Compensate for Local Anesthetic Cytotoxic Effects on Tenocytes: Morphine or Morphine Plus Dexamethasone May Be a Safe Alternative.

Authors:  Anne Lene Oeyen; Jörn Kircher; Melanie Vogl; Irina Ickert; Nani Osada; Rüdiger Krauspe; Bernd Bittersohl; Monika Herten
Journal:  Arthrosc Sports Med Rehabil       Date:  2021-12-23

9.  Assessment of Intraoperative Intra-articular Morphine and Clonidine Injection in the Acute Postoperative Period After Hip Arthroscopy.

Authors:  Charles J Cogan; Michael Knesek; Vehniah K Tjong; Rueben Nair; Cynthia Kahlenberg; Kevin F Dunne; Mark C Kendall; Michael A Terry
Journal:  Orthop J Sports Med       Date:  2016-02-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.